Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
December 30, 2025 Clinical supply chain leaders are entering 2026 with a new mandate: control costs without compromising flexibility, quality, or patient access. The pressure is real—and the organizations that get this right will accelerate development while everyone else fights fires. Here’s what’s driving the urgency: 🔹 Rising manufacturing & packaging costs Energy, […]
Clinical Supply Chains Are Entering Their “AI‑Native” Era — And 2026 Is the Breakout Year For decades, clinical supply has been treated as a back‑office function. In 2026, it’s becoming a strategic engine — one that accelerates development timelines, reduces cost, and expands global patient access. The catalyst? AI is no longer an experiment. It’s the new […]
https://www.linkedin.com/in/jgoberlander/?lipi=urn%3Ali%3Apage%3Ad_flagship3_pulse_read%3B6xTGMp88S8yrUkVanKmQOw%3D%3D Joseph G. Oberlander, Ph.D., PMP Program Manager ♦ Neuroscientist ♦ Author Clinical trials are the backbone of medical innovation, but their supply chains have traditionally been complex, fragmented, and vulnerable to disruption. From ensuring investigational drugs reach patients on time to managing global logistics, the stakes are high. Artificial Intelligence (AI) is now emerging […]
As 2025 closes, several December analyses across healthcare and supply chain publications point to the same conclusion: clinical supply chains are entering 2026 with higher volatility, tighter capacity, and increasing regulatory scrutiny — but also unprecedented opportunities for digital acceleration. A few patterns stand out: 1. Non‑labor cost pressure is now a structural reality, not […]